Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Teva Pharmaceutical Industries Ltd (TEVA) CEO Kare Schultz on Q3 2020 Results - Earnings Call Transcript
04:47pm, Thursday, 05'th Nov 2020
Teva Pharmaceutical Industries Ltd (TEVA) CEO Kare Schultz on Q3 2020 Results - Earnings Call Transcript
Generic Pharma Behemoth Skids As Earnings Stall, Sales Lag Forecasts
09:05am, Thursday, 05'th Nov 2020
Early Thursday, Teva Pharmaceutical reported adjusted earnings of 58 cents per share on $3.98 billion in sales for its third quarter ended Sept. 30. In response, Teva stock slipped.
TEVA DEADLINE ALERT
08:55pm, Wednesday, 04'th Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
Teva Deadline Alert
08:33pm, Monday, 02'nd Nov 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Nove
Miller Value Partners is Betting on Teva Pharmaceutical Industries (TEVA) Stock
11:10am, Monday, 02'nd Nov 2020
Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The Opportunity Equity Fund posted a return of 13.01% for the quarter (net of fees), outperf
NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) between Octo
New York, New York--(Newsfile Corp. - October 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE
4 Top Value Stocks on Sale to Buy Right Now
06:06am, Wednesday, 28'th Oct 2020
Bargains abound for long-term investors.
Teva Shareholder Alert
09:13pm, Tuesday, 27'th Oct 2020
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - Octo
